Impact of SOD1 Transcript Variants on Amyotrophic Lateral Sclerosis Severity

Area of Science:

• Neuroscience
• Genetics
• Biochemistry

Background:

• Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease impacting motor neurons.
• Mutations in the superoxide dismutase 1 (SOD1) gene are implicated in ALS pathogenesis.
• Two SOD1 transcripts, short and long, have been previously identified.

Purpose of the Study:

• To investigate the role and expression of short and long SOD1 transcripts in ALS.
• To determine if SOD1 transcripts correlate with disease severity, progression, or patient age.
• To explore the potential of SOD1 transcripts as biomarkers for ALS.

Main Methods:

• Analysis of SOD1 transcripts in the SH-SY5Y cell line under stress conditions.
• Examination of SOD1 transcripts in peripheral blood mononuclear cells from ALS patients.
• Correlation analysis between SOD1 transcript levels and clinical parameters (severity, progression, age).

Main Results:

• The shortest SOD1 transcript was found to be upregulated under stress in both cellular models and patient cells.
• A potential correlation was observed between the short SOD1 transcript and ALS severity, as well as patient age.
• No correlation was found between SOD1 transcript levels and ALS disease progression.

Conclusions:

• Short SOD1 transcripts may exert a toxic effect contributing to ALS severity.
• Short SOD1 transcripts show potential as a biomarker for ALS severity.
• Short SOD1 transcripts do not appear to influence or drive ALS disease progression.